A Phase III trial of A-101 (45% topical solution) for the treatment of warts

Trial Profile

A Phase III trial of A-101 (45% topical solution) for the treatment of warts

Planning
Phase of Trial: Phase III

Latest Information Update: 08 May 2018

At a glance

  • Drugs Hydrogen peroxide (Primary)
  • Indications Warts
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 May 2018 According to an Aclaris Therapeutics media release, company expects to initiate this trial in the second half of 2018.
    • 23 Mar 2018 New trial record
    • 19 Mar 2018 According to an Aclaris Therapeutics media release, the Company expects to initiate the Phase III program in second quarter of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top